| 项目编号 |
PRJCA035488 |
| 项目标题 |
Efficacy, Safety, and Biomarker Analysis of First-Line Immune Checkpoint Inhibitors with Chemotherapy versus Chemotherapy for Advanced Gastric Cancer |
| 涉及领域 |
Medical |
| 数据类型 |
Transcriptome or Gene expression
Variation
Clinical information
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
Efficacy, Safety, and Biomarker Analysis of First-Line Immune Checkpoint Inhibitors with Chemotherapy versus Chemotherapy for Advanced Gastric Cancer: A Multicenter, Retrospective Cohort Study |
| 样品范围 |
Multiisolate |
| 发布日期 |
2025-01-24 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 39696266
|
|
|
|
|
|
|
Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a …
|
BMC Medicine
|
10.1186/s12916-024-03801-5
|
2025
|
| 39939996
|
Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study
|
BMC Medicine
|
10.1186/s12916-025-03938-x
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| National Natural Science Foundation of China (NSFC)
|
|
82173305
|
|
|
|
| 提交者 |
Lian
Liu (lianliu@sdu.edu.cn)
|
| 提交单位 |
Qilu Hospital, Shandong University |
| 提交日期 |
2025-01-23 |
